Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel P Lew

Showing results (1-10 of 36) with videos related to

Pageof 4
Sort By:
Revue Medicale Suisse|June 5, 2009
[Outpatient antibiotic use in urgent care - a controversy]Daniel P Lew, Thierry Calandra
Injury|May 3, 2006
Tolerance of staphylococci to bactericidal antibioticsPierre Vaudaux, Daniel P Lew
Revue Medicale Suisse|May 4, 2010
[Holy virus!]Thierry Calandra, Daniel P Lew
Lancet (London, England)|July 28, 2004
OsteomyelitisDaniel P Lew, Francis A Waldvogel
Journal of Cell Science|June 26, 2002
Granule-specific ATP requirements for Ca2+-induced exocytosis in human neutrophils. Evidence for substantial ATP-independent releaseSten Theander, Daniel P Lew, Oliver Nüsse
The Journal of Infectious Diseases|August 21, 2012
Antimicrobial peptide exposure and reduced susceptibility to daptomycin: insights into a complex genetic puzzleWilliam L Kelley, Daniel P Lew, Adriana Renzoni
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 20, 2006
Staphylococcus aureus small colony variants: difficult to diagnose and difficult to treatPierre Vaudaux, William L Kelley, Daniel P Lew
BMC Infectious Diseases|April 13, 2006
Evaluation of high-dose daptomycin for therapy of experimental Staphylococcus aureus foreign body infectionHeinz J Schaad, Manuela Bento, Daniel P Lew, et al.
Antimicrobial Agents and Chemotherapy|April 18, 2002
Comparison of levofloxacin, alatrofloxacin, and vancomycin for prophylaxis and treatment of experimental foreign-body-associated infection by methicillin-resistant Staphylococcus aureusPierre Vaudaux, Patrice Francois, Carmelo Bisognano, et al.
Antimicrobial Agents and Chemotherapy|May 1, 2013
The Staphylococcus aureus thiol/oxidative stress global regulator Spx controls trfA, a gene implicated in cell wall antibiotic resistanceAmbre Jousselin, William L Kelley, Christine Barras, et al.
Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
Revue Medicale Suisse|June 5, 2009
[Outpatient antibiotic use in urgent care - a controversy]Daniel P Lew, Thierry Calandra
Injury|May 3, 2006
Tolerance of staphylococci to bactericidal antibioticsPierre Vaudaux, Daniel P Lew
Revue Medicale Suisse|May 4, 2010
[Holy virus!]Thierry Calandra, Daniel P Lew
Lancet (London, England)|July 28, 2004
OsteomyelitisDaniel P Lew, Francis A Waldvogel
Journal of Cell Science|June 26, 2002
Granule-specific ATP requirements for Ca2+-induced exocytosis in human neutrophils. Evidence for substantial ATP-independent releaseSten Theander, Daniel P Lew, Oliver Nüsse
The Journal of Infectious Diseases|August 21, 2012
Antimicrobial peptide exposure and reduced susceptibility to daptomycin: insights into a complex genetic puzzleWilliam L Kelley, Daniel P Lew, Adriana Renzoni
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 20, 2006
Staphylococcus aureus small colony variants: difficult to diagnose and difficult to treatPierre Vaudaux, William L Kelley, Daniel P Lew
BMC Infectious Diseases|April 13, 2006
Evaluation of high-dose daptomycin for therapy of experimental Staphylococcus aureus foreign body infectionHeinz J Schaad, Manuela Bento, Daniel P Lew, et al.
Antimicrobial Agents and Chemotherapy|April 18, 2002
Comparison of levofloxacin, alatrofloxacin, and vancomycin for prophylaxis and treatment of experimental foreign-body-associated infection by methicillin-resistant Staphylococcus aureusPierre Vaudaux, Patrice Francois, Carmelo Bisognano, et al.
Antimicrobial Agents and Chemotherapy|May 1, 2013
The Staphylococcus aureus thiol/oxidative stress global regulator Spx controls trfA, a gene implicated in cell wall antibiotic resistanceAmbre Jousselin, William L Kelley, Christine Barras, et al.
Pageof 4